Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | — |
The patient took couple doses of Vivotif and then went somewhere and forgot to take the rest of the vaccine; Case reference number US-BN-2025-001202 is a spontaneous case initially received from a nurse via Communication (reference number: USBAV25-1680) on 10-Jul-2025 and concerns a patient of unspecified age and gender. The patient's medical history and concomitant medication details were not provided. On unspecified dates, the patient took the couple of doses of Vivotif (batch number: unknown) at an unknown dose, route or site of administration for an unknown indication, and then went somewhere and forgot to take the rest of the vaccine (explicitly coded as incomplete course of vaccination'). At the time of the initial report, it was unknown if the patient experienced any adverse events due to Vivotif. No further information was provided.; Reporter's Comments: This case concerned a patient of unspecified age and gender. On unspecified dates, the patient took the couple of doses of Vivotif for an unknown indication and then went somewhere and forgot to take the rest of the vaccine which is considered as incomplete course of vaccination. At the time of the initial report, it was unknown if the patient experienced any adverse events due to Vivotif. Incomplete course of vaccination is considered as listed as per company convention. The patients' medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: This case concerned a patient of unspecified age and gender. On unspecified dates, the patient took the couple of doses of Vivotif for an unknown indication and then went somewhere and forgot to take the rest of the vaccine which is considered as incomplete course of vaccination. At the time of the initial report, it was unknown if the patient experienced any adverse events due to Vivotif. Incomplete course of vaccination is considered as listed as per company convention. The patients' medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE